2,249
Views
6
CrossRef citations to date
0
Altmetric
Neurology

Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar

, , , , , , , , & show all
Pages 439-458 | Received 28 Jul 2016, Accepted 10 Nov 2016, Published online: 31 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Dirk Deleu, Beatriz Canibaño, Boulenouar Mesraoua, Gholamreza Adeli, Mohamed S. Abdelmoneim, Yasir Ali, Osama Elalamy, Gayane Melikyan & Amir Boshra. (2020) Management of relapsing–remitting multiple sclerosis in Qatar: an expert consensus. Current Medical Research and Opinion 36:2, pages 251-260.
Read now
Beatriz Canibaño, Dirk Deleu, Boulenouar Mesraoua, Gayane Melikyan, Faiza Ibrahim & Yolande Hanssens. (2020) Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations. Journal of Drug Assessment 9:1, pages 20-36.
Read now
Dirk Deleu, Boulenouar Mesraoua, Beatriz Canibaño, Gayane Melikyan, Hassan Al Hail, Lubna El-Sheikh, Musab Ali, Hassan Al Hussein, Faiza Ibrahim & Yolande Hanssens. (2019) Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overview. Current Medical Research and Opinion 35:2, pages 249-260.
Read now

Articles from other publishers (3)

Reinier Cardentey Sánchez, Amado Díaz Fe, Alejandro Peláez Suarez, Dayme Grass, Teresa Morgado Vega, Armando Sánchez Canal, Dario Siniscalco & María Angeles Robinson Agramonte. (2021) Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosis. Drug Development Research 82:5, pages 707-715.
Crossref
Beatriz Canibaño, Musab Ali, Boulenouar Mesraoua, Gayane Melikyan, Hasan Al Hail, Faiza Ibrahim, Yolande Hanssens & Dirk Deleu. (2020) Severe rebound disease activity after fingolimod withdrawal in a pregnant woman with multiple sclerosis managed with rituximab: A case study. Case Reports in Women's Health 25, pages e00162.
Crossref
Yang Hu, Hao Nie, Hai-Han Yu, Chuan Qin, Long-Jun Wu, Zhou-Ping Tang & Dai-Shi Tian. (2019) Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis. Autoimmunity Reviews 18:5, pages 542-548.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.